{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:13:48Z","timestamp":1788984828401,"version":"build-2803163510"},"reference-count":131,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,14]],"date-time":"2027-01-14T00:00:00Z","timestamp":1799884800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.disamonth.2025.102027","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T06:15:58Z","timestamp":1761632158000},"page":"102027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic kidney disease for the primary care provider"],"prefix":"10.1016","volume":"72","author":[{"given":"William","family":"Doak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2025.102027_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1499225","article-title":"Trends in the prevalence of Chronic Kidney Disease in the United States, 1999\u20132018","volume":"11","author":"Zhuang","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.disamonth.2025.102027_bib0002","unstructured":"Annual Data Report. USRDS. Accessed September 20, 2025. https:\/\/usrds-adr.niddk.nih.gov\/."},{"issue":"3, Supplement 2","key":"10.1016\/j.disamonth.2025.102027_bib0003","first-page":"S10","article-title":"The expanding role of primary care providers in care of individuals with kidney disease","volume":"114","author":"Martin","year":"2022","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2021.09.003","article-title":"CKD prevalence among patients with and without type 2 diabetes: regional differences in the United States","volume":"4","author":"Feng","year":"2021","journal-title":"Kidney Med"},{"issue":"10225","key":"10.1016\/j.disamonth.2025.102027_bib0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.34067\/KID.0000000000000335","article-title":"International variability in the epidemiology, management, and outcomes of CKD and ESKD: a systematic review","volume":"360","author":"Freedberg","year":"2024","journal-title":"Kidney"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102027_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229649","article-title":"The epidemiology of chronic kidney disease (CKD) in rural East Africa: a population-based study","volume":"15","author":"Muiru","year":"2020","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0008","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2215\/CJN.03700417","article-title":"Diabetes and CKD in the United States population, 2009\u20132014","volume":"12","author":"Zelnick","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102027_bib0009","doi-asserted-by":"crossref","first-page":"352","DOI":"10.34067\/KID.0000000000000374","article-title":"Mortality, health care burden, and treatment of CKD: a multinational, observational study (OPTIMISE-CKD)","volume":"360","author":"Tangri","year":"2024","journal-title":"Kidney"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ajkd.2008.07.034","article-title":"Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999\u20132004","volume":"53","author":"Snyder","year":"2009","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0011","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2215\/CJN.02400310","article-title":"Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES","volume":"5","author":"Gambaro","year":"2010","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102027_bib0012","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41581-024-00863-9","article-title":"The impact of population ageing on the burden of chronic kidney disease","volume":"20","author":"Chesnaye","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0013","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrneph.2014.242","article-title":"Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes","volume":"11","author":"Sarafidis","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.disamonth.2025.102027_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12875-023-02077-7","article-title":"Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death","volume":"24","author":"Borg","year":"2023","journal-title":"BMC Prim Care"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2215\/CJN.03610414","article-title":"Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD","volume":"10","author":"Tsai","year":"2015","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102027_bib0016","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1007\/s12325-024-02957-z","article-title":"Early Identification and management of chronic kidney disease: a narrative review of the crucial role of primary care practitioners","volume":"41","author":"Kushner","year":"2024","journal-title":"Adv Ther"},{"issue":"10S","key":"10.1016\/j.disamonth.2025.102027_bib0017","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1681\/ASN.20203110S1228b","article-title":"The Practical Patterns of Medication and the Association between CKD Stage and polypharmacy: the Fukuoka Kidney Disease Registry Study PO0585","volume":"31","author":"Hara","year":"2020","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.disamonth.2025.102027_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1122898","article-title":"Prevalence and global trends of polypharmacy in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"14","author":"Naseralallah","year":"2023","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0019","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/ckj\/sfab120","article-title":"Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls","volume":"14","author":"van Oosten","year":"2021","journal-title":"Clin Kidney J"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102027_bib0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5414\/CP204249","article-title":"Evaluation of polypharmacy among chronic kidney disease patients in Egypt: a cross-sectional study","volume":"60","author":"Gawad","year":"2022","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0021","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2215\/CJN.03940321","article-title":"Association of polypharmacy with Kidney disease progression in adults with CKD","volume":"16","author":"Kimura","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.disamonth.2025.102027_bib0022","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10157-022-02306-w","article-title":"Association of polypharmacy with incidence of CKD: a retrospective cohort study - ProQuest","volume":"27","author":"Kimura","year":"2022","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102027_bib0023","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2215\/CJN.01030120","article-title":"Adverse drug reactions in patients with CKD","volume":"15","author":"Laville","year":"2020","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12882-020-01788-8","article-title":"Developing quality indicators for Chronic Kidney Disease in primary care, extractable from the Electronic Medical Record. A Rand-modified Delphi method","volume":"21","author":"Van den Bulck","year":"2020","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-025-03967-x","article-title":"Uncoded chronic kidney disease prevalence in secondary care: a retrospective audit with population health implications","volume":"26","author":"Dolan","year":"2025","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0026","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ekir.2023.11.022","article-title":"The prevalence of CKD in Australian primary care: analysis of a national general practice dataset","volume":"9","author":"Jun","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0027","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1681\/ASN.2020091298","article-title":"Advance care planning in older adults with CKD: patient, care partner, and clinician perspectives","volume":"32","author":"Ladin","year":"2021","journal-title":"J Am Soc Nephrol JASN"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0028","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2215\/CJN.06790617","article-title":"Medication therapy management after hospitalization in CKD","volume":"13","author":"Tuttle","year":"2018","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0029","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ackd.2017.10.006","article-title":"Challenges in measuring glomerular filtration rate: a clinical laboratory perspective","volume":"25","author":"Seegmiller","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102027_bib0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.ajkd.2021.04.016","article-title":"Measurement and estimation of GFR for use in clinical practice: core curriculum 2021","volume":"78","author":"Inker","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0031","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ajhp\/zxae317","volume":"82","author":"St Peter","year":"2025","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0032","first-page":"A1","article-title":"2024 Clinical pracitice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102027_bib0033","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1681\/ASN.0000000000000128","article-title":"Accuracy of GFR estimating equations in patients with discordances between creatinine and Cystatin C-based estimations","volume":"34","author":"Fu","year":"2023","journal-title":"J Am Soc Nephrol JASN"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102027_bib0034","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.34067\/KID.0003202022","article-title":"Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR","volume":"360","author":"Chen","year":"2022","journal-title":"Kidney"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0035","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2020.07.010","article-title":"Differences between cystatin C\u2013 and creatinine-based estimated GFR\u2014Early evidence of a clinical marker for frailty","volume":"76","author":"McAdams-DeMarco","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102027_bib0036","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2022.12407","article-title":"Serum cystatin C for estimation of GFR","volume":"328","author":"Shlipak","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2025.102027_bib0037","unstructured":"The kidney failure risk equation. Accessed August 28, 2025. http:\/\/kidneyfailurerisk.com."},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0038","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s11255-022-03210-8","article-title":"CKD prevalence based on real-world data: continuous age-dependent lower reference limits of eGFR with CKD\u2013EPI, FAS and EKFC algorithms","volume":"54","author":"Adler","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0039","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pop.2020.08.001","article-title":"Chronic kidney disease","volume":"47","author":"Charles","year":"2020","journal-title":"Prim Care Clin Off Pract"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2215\/CJN.07830520","article-title":"Risk factors for CKD progression","volume":"16","author":"Hannan","year":"2021","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0041","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2015.172","article-title":"Hypertension-attributed nephropathy: what\u2019s in a name?","volume":"12","author":"Freedman","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102027_bib0042","first-page":"233","article-title":"Information and consensus document for the detection and management of chronic kidney disease","volume":"42","author":"Garc\u00eda-Maset","year":"2022","journal-title":"Nefrol Engl Ed"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2025.100979","article-title":"Risk factor-based screening for early detection of chronic kidney disease in primary care settings: a systematic review","volume":"7","author":"Korsa","year":"2025","journal-title":"Kidney Med"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102027_bib0044","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.27396","article-title":"Diagnostic yield of population-based screening for chronic kidney disease in low-income, middle-income, and high-income countries","volume":"4","author":"Tonelli","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0045","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/biomedicines12112622","article-title":"Epigenetics of hypertensive nephropathy","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0046","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ckj\/sfaa162","article-title":"Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology","volume":"13","author":"Carriazo","year":"2020","journal-title":"Clin Kidney J"},{"issue":"23","key":"10.1016\/j.disamonth.2025.102027_bib0047","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1056\/NEJMra1916393","article-title":"Cardiovascular consequences of acute kidney injury","volume":"382","author":"Legrand","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0048","doi-asserted-by":"crossref","first-page":"752","DOI":"10.34067\/KID.0003122021","article-title":"Modifiable lifestyle behaviors and CKD progression: a narrative review","volume":"360","author":"Schrauben","year":"2022","journal-title":"Kidney"},{"issue":"22","key":"10.1016\/j.disamonth.2025.102027_bib0049","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.disamonth.2025.102027_bib0050","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.disamonth.2025.102027_bib0051","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0052","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0053","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: core curriculum 2019","volume":"74","author":"Ku","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102027_bib0054","doi-asserted-by":"crossref","first-page":"sfaf229","DOI":"10.1093\/ckj\/sfaf229","article-title":"Hypertension burden in CKD: is nocturnal hypertension the primary culprit?","volume":"18","author":"Mallamaci","year":"2025","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41440-023-01368-x","article-title":"Nocturnal systolic blood pressure dipping and progression of chronic kidney disease","volume":"47","author":"Park","year":"2024","journal-title":"Hypertens Res"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102027_bib0056","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41581-024-00848-8","article-title":"Sleep disorders in chronic kidney disease","volume":"20","author":"Lyons","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0057","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.ajkd.2024.12.010","article-title":"Sleep Disorders in CKD: a review","volume":"85","author":"Gopal","year":"2025","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102027_bib0058","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/M23-3236","article-title":"Angiotensin-converting enzyme inhibitors or Angiotensin-receptor blockers for advanced chronic kidney disease: a systematic review and retrospective individual participant\u2013Level meta-analysis of clinical trials","volume":"177","author":"Ku","year":"2024","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102027_bib0059","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1681\/ASN.0000000000000426","article-title":"Association between acute declines in eGFR during Renin-Angiotensin system inhibition and risk of adverse outcomes","volume":"35","author":"Ku","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.disamonth.2025.102027_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9162427","article-title":"IgA nephropathy with macroproteinuria and a GFR of 20-30\u2009ml\/min\/1.73\u2009m2 may still benefit from RAS inhibition","volume":"2022","author":"Wang","year":"2022","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0061","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1681\/ASN.2020050682","article-title":"Stopping renin-Angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study","volume":"32","author":"Fu","year":"2021","journal-title":"J Am Soc Nephrol JASN"},{"issue":"22","key":"10.1016\/j.disamonth.2025.102027_bib0062","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa2210639","article-title":"Renin\u2013Angiotensin system inhibition in advanced chronic kidney disease","volume":"387","author":"Bhandari","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0063","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11906-023-01265-1","article-title":"Management of hyperkalemia in patients with chronic kidney disease using renin angiotensin aldosterone system inhibitors","volume":"25","author":"Fravel","year":"2023","journal-title":"Curr Hypertens Rep"},{"issue":"7\u20138","key":"10.1016\/j.disamonth.2025.102027_bib0064","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000531102","article-title":"Discontinuation of renin-angiotensin-aldosterone system inhibitors secondary to hyperkalemia translates into higher cardiorenal outcomes","volume":"54","author":"An","year":"2023","journal-title":"Am J Nephrol"},{"issue":"24","key":"10.1016\/j.disamonth.2025.102027_bib0065","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.disamonth.2025.102027_bib0066","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0067","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0068","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.0000000000000248","article-title":"Effect of SGLT2 inhibitors on discontinuation of renin\u2013angiotensin system blockade: a joint analysis of the CREDENCE and DAPA-CKD trials","volume":"34","author":"Fletcher","year":"2023","journal-title":"J Am Soc Nephrol JASN"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0069","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/s41591-024-03263-5","article-title":"Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial","volume":"30","author":"Hobbs","year":"2024","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102027_bib0070","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1681\/ASN.2022020207","article-title":"Albuminuria-lowering effect of Dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized crossover clinical trial","volume":"33","author":"Provenzano","year":"2022","journal-title":"J Am Soc Nephrol JASN"},{"issue":"31","key":"10.1016\/j.disamonth.2025.102027_bib0071","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1093\/eurheartj\/ehac299","article-title":"Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease","volume":"43","author":"Pandey","year":"2022","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.disamonth.2025.102027_bib0072","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0073","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.disamonth.2025.102027_bib0074","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102027_bib0075","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.ajkd.2022.04.016","article-title":"Mineralocorticoid receptor activation, and CKD: a review of evolving treatment paradigms","volume":"80","author":"Epstein","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0076","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehae613","article-title":"Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial","volume":"46","author":"Mahaffey","year":"2025","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0077","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41591-024-03327-6","article-title":"Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial","volume":"31","author":"Apperloo","year":"2025","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0078","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc22-1889","article-title":"Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials","volume":"46","author":"Heerspink","year":"2023","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.disamonth.2025.102027_bib0079","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.121.055459","article-title":"Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER","volume":"145","author":"Shaman","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","article-title":"Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria","volume":"149","author":"Neuen","year":"2024","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0081","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2410659","article-title":"Finerenone with Empagliflozin in chronic kidney disease and type 2 diabetes","volume":"393","author":"Agarwal","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.disamonth.2025.102027_bib0082","first-page":"1746","article-title":"Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease","volume":"40","author":"Bakker","year":"2025","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0083","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2215\/CJN.0000000000000221","article-title":"Will SGLT2 inhibitors Be effective and safe in patients with severe CKD, dialysis, or kidney transplantation","volume":"18","author":"Heerspink","year":"2023","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0084","first-page":"308","article-title":"Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with non-diabetic Chronic Kidney Disease (FIND-CKD) randomized trial","volume":"40","author":"Heerspink","year":"2025","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"16","key":"10.1016\/j.disamonth.2025.102027_bib0085","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.disamonth.2025.102027_bib0086","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMe2411214","article-title":"FINEARTS-HF \u2014 The latest masterpiece for MRAs in heart failure","volume":"391","author":"McDonagh","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102027_bib0087","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/dom.16371","article-title":"The interplay between heart failure and chronic kidney disease","volume":"27","author":"Lala","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.disamonth.2025.102027_bib0088","unstructured":"Optimization of RAASi Therapy Toolkit. International Society of Nephrology. Accessed September 28, 2025. https:\/\/www.theisn.org\/initiatives\/toolkits\/raasi-toolkit\/."},{"key":"10.1016\/j.disamonth.2025.102027_bib0089","unstructured":"Optimization of SGLT2i Therapy Toolkit. International Society of Nephrology. Accessed September 28, 2025. https:\/\/www.theisn.org\/initiatives\/toolkits\/sglt2i-toolkit\/."},{"key":"10.1016\/j.disamonth.2025.102027_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.119042","article-title":"The role of maintaining lower LDL-C level during statin treatment for advanced CKD patients","volume":"399","author":"Yen","year":"2024","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0091","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40266-018-0593-8","article-title":"The role of deprescribing in older adults with chronic kidney disease","volume":"35","author":"Triantafylidis","year":"2018","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0092","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41581-024-00823-3","article-title":"Drug stewardship in chronic kidney disease to achieve effective and safe medication use","volume":"20","author":"Hall","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0093","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.amjms.2023.10.003","article-title":"Polypharmacy in chronic kidney disease: health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy","volume":"367","author":"Onor","year":"2024","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0094","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.ASN.0000046047.66958.C3","article-title":"A propensity analysis of late versus early nephrologist referral and mortality on dialysis","volume":"14","author":"Winkelmayer","year":"2003","journal-title":"J Am Soc Nephrol JASN"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102027_bib0095","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1523-1755.2005.00168.x","article-title":"Does predialysis nephrology care influence patient survival after initiation of dialysis?","volume":"67","author":"Khan","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102027_bib0096","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0272-6386(03)00805-9","article-title":"Impact of nephrology referral on early and midterm outcomes in ESRD: ePid\u00e9miologie de l\u2019Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study","volume":"42","author":"Kessler","year":"2003","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0097","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.amjmed.2007.04.024","article-title":"Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis","volume":"120","author":"Chan","year":"2007","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102027_bib0098","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.ajkd.2021.09.020","article-title":"Too many for Too few: finding appropriate nephrology referrals for patients with CKD that optimize outcomes","volume":"79","author":"Chu","year":"2022","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"10.1016\/j.disamonth.2025.102027_bib0099","first-page":"gfaf128","article-title":"Risk-based referral model to nephrologist specialist care in Stockholm","author":"Caldinelli","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0100","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/ckj\/sfac104","article-title":"Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease","volume":"15","author":"Oliva-Damaso","year":"2022","journal-title":"Clin Kidney J"},{"issue":"727","key":"10.1016\/j.disamonth.2025.102027_bib0101","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.3399\/BJGP.2022.0145","article-title":"Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study","volume":"73","author":"Sullivan","year":"2023","journal-title":"Br J Gen Pract J R Coll Gen Pract"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0102","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12875-022-01910-9","article-title":"Albuminuria testing and nephrology care among insured US adults with chronic kidney disease: a missed opportunity","volume":"23","author":"Chu","year":"2022","journal-title":"BMC Prim Care"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0103","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12882-024-03717-5","article-title":"Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery","volume":"25","author":"Cesar","year":"2024","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102027_bib0104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.ackd.2012.07.004","article-title":"Evolving strategies in the diagnosis, treatment, and monitoring of myeloma kidney","volume":"19","author":"Hutchison","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41408-023-00806-w","article-title":"Multiple myeloma with acute light chain cast nephropathy","volume":"13","author":"Leung","year":"2023","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0106","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.disamonth.2025.102027_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103926","article-title":"Monoclonal gammopathy of renal significance: multidisciplinary approach to diagnosis and treatment","volume":"183","author":"Karam","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"20","key":"10.1016\/j.disamonth.2025.102027_bib0108","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102027_bib0110","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s11606-019-04975-y","article-title":"Primary care physicians\u2019 Perceived barriers to nephrology referral and Co-management of patients with CKD: a qualitative study","volume":"34","author":"Greer","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"12","key":"10.1016\/j.disamonth.2025.102027_bib0111","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2215\/CJN.00650114","article-title":"A palliative approach to dialysis care: a patient-centered transition to the end of life","volume":"9","author":"Grubbs","year":"2014","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151397","article-title":"Dialysis access considerations in kidney palliative care","volume":"43","author":"Gelfand","year":"2023","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102027_bib0113","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.ajkd.2022.02.017","article-title":"Shared decision making among older adults with advanced CKD","volume":"80","author":"Frazier","year":"2022","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.kint.2019.01.017","article-title":"Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"96","author":"Chan","year":"2019","journal-title":"Kidney Int"},{"issue":"18","key":"10.1016\/j.disamonth.2025.102027_bib0115","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/jama.2024.16338","article-title":"Dialysis for chronic kidney failure: a review","volume":"332","author":"Flythe","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0116","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2215\/CJN.0000000000000424","article-title":"From home to wearable hemodialysis: barriers, progress, and opportunities","volume":"19","author":"Rivara","year":"2024","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0117","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.ajkd.2022.07.004","article-title":"Peritoneal dialysis prescription and adequacy in clinical practice: core curriculum 2023","volume":"81","author":"Auguste","year":"2023","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0118","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/08968608221114211","article-title":"Peritoneal dialysis in the modern era","volume":"43","author":"Karkar","year":"2023","journal-title":"Perit Dial Int"},{"issue":"15","key":"10.1016\/j.disamonth.2025.102027_bib0119","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2024.0535","article-title":"Arteriovenous access for hemodialysis: a review","volume":"331","author":"Lok","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.disamonth.2025.102027_bib0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.ajkd.2024.05.021","article-title":"Hemodialysis Vascular access: core curriculum 2025","volume":"85","author":"Lok","year":"2025","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0121","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ackd.2016.04.001","article-title":"Preparation of the dialysis access in stages 4 and 5 CKD","volume":"23","author":"Moist","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0122","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.ajkd.2020.11.027","article-title":"New Devices and Technologies for Hemodialysis Vascular Access: a review","volume":"78","author":"Vachharajani","year":"2021","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.semvascsurg.2024.10.002","article-title":"Peritoneal dialysis catheter insertion and maintenance","volume":"37","author":"Wynn","year":"2024","journal-title":"Semin Vasc Surg"},{"issue":"5","key":"10.1016\/j.disamonth.2025.102027_bib0124","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3747\/pdi.2018.00232","article-title":"Creating and maintaining optimal peritoneal dialysis access in the adult patient: 2019 update","volume":"39","author":"Crabtree","year":"2019","journal-title":"Perit Dial Int J Int Soc Perit Dial"},{"issue":"3","key":"10.1016\/j.disamonth.2025.102027_bib0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3747\/pdi.2017.00230","article-title":"Advanced Laparoscopic peritoneal Dialysis catheter Insertion: systematic review and meta-analysis","volume":"38","author":"Shrestha","year":"2018","journal-title":"Perit Dial Int J Int Soc Perit Dial"},{"issue":"10","key":"10.1016\/j.disamonth.2025.102027_bib0126","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"6","key":"10.1016\/j.disamonth.2025.102027_bib0127","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/sdi.12921","article-title":"Barriers to kidney transplantation in ESKD","volume":"33","author":"Venkataraman","year":"2020","journal-title":"Semin Dial"},{"issue":"11","key":"10.1016\/j.disamonth.2025.102027_bib0128","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41581-023-00745-6","article-title":"Inequities in kidney health and kidney care","volume":"19","author":"Vanholder","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.102027_bib0129","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11606-010-1354-5","article-title":"Primary care of the renal transplant patient","volume":"25","author":"Gupta","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.102027_bib0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.pop.2020.08.007","article-title":"Care of the renal transplant patient","volume":"47","author":"Foster","year":"2020","journal-title":"Prim Care"},{"issue":"1","key":"10.1016\/j.disamonth.2025.102027_bib0131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12882-024-03504-2","article-title":"Management of kidney transplant recipients for primary care practitioners","volume":"25","author":"Alotaibi","year":"2024","journal-title":"BMC Nephrol"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502925001816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502925001816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:32:25Z","timestamp":1788982345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502925001816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0011502925001816"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2025.102027","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease for the primary care provider","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2025.102027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102027"}}